It turned out that rate of cost to selling price of multinational pharmaceutical companies was average 66.6%
According to the 2013 audit report of 33 multinational pharmaceutical companies, it turned out that their rate of cost to selling price was average 66.6%. This figure is about 8% higher than that of 44 domestic listed pharmaceutical companies (58.7%), and 77 non-listed pharmaceutical companies (5...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
